{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T19:56:56Z","timestamp":1791230216189,"version":"4.1.0"},"reference-count":44,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100011671","name":"G Harold and Leila Y Mathers Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011671","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017183","name":"Janssen Scientific Affairs LLC","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017183","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004898","name":"Commonwealth of Pennsylvania Department of Labor and Industry","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004898","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Microbes and Infection"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.micinf.2022.105082","type":"journal-article","created":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T11:00:35Z","timestamp":1671274835000},"page":"105082","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Heterologous chimpanzee adenovirus vector immunizations for SARS-CoV-2 spike and nucleocapsid protect hamsters against COVID-19"],"prefix":"10.1016","volume":"25","author":[{"given":"Mohadeseh","family":"Hasanpourghadi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikhail","family":"Novikov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Ambrose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arezki","family":"Chekaoui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3835-0853","authenticated-orcid":false,"given":"Dakota","family":"Newman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianyi","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wynetta","family":"Giles-Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiquan","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang Yang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9964-580X","authenticated-orcid":false,"given":"Qin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kar","family":"Swagata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9795-5206","authenticated-orcid":false,"given":"Hildegund CJ.","family":"Ertl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.micinf.2022.105082_bib1","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/s41586-021-04388-0","article-title":"Striking antibody evasion manifested by the Omicron variant of SARS-CoV-2","volume":"602","author":"Liu","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.micinf.2022.105082_bib2","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJMoa2035389","article-title":"Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine","volume":"384","author":"Baden","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.micinf.2022.105082_bib3","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.micinf.2022.105082_bib4","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2101544","article-title":"Safety and efficacy of single-dose Ad26.COV2.S vaccine against Covid-19","author":"Sadoff","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.micinf.2022.105082_bib5","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1016\/S0140-6736(21)00628-0","article-title":"Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012\/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial","volume":"397","author":"Emary","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.micinf.2022.105082_bib6","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S0140-6736(21)00234-8","article-title":"Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia","volume":"397","author":"Logunov","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.micinf.2022.105082_bib7","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0140-6736(22)00055-1","article-title":"Efficacy of the adjuvanted subunit protein COVID-19 vaccine, SCB-2019: a phase 2 and 3 multicentre, double-blind, randomised, placebo-controlled trial","volume":"399","author":"Bravo","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.micinf.2022.105082_bib8","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S1473-3099(20)30843-4","article-title":"Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18\u201359 years: a randomised, double-blind, placebo-controlled, phase 1\/2 clinical trial","volume":"21","author":"Zhang","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.micinf.2022.105082_bib9","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/s41392-021-00523-5","article-title":"SARS-CoV-2 spike protein: a key target for eliciting persistent neutralizing antibodies","volume":"6","author":"Yang","year":"2021","journal-title":"Signal Transduct Targeted Ther"},{"key":"10.1016\/j.micinf.2022.105082_bib10","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/s41586-020-03041-6","article-title":"Correlates of protection against SARS-CoV-2 in rhesus macaques","volume":"590","author":"McMahan","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.micinf.2022.105082_bib11","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1038\/s41591-021-01527-y","article-title":"Safety and immunogenicity of SARS-CoV-2 variant mRNA vaccine boosters in healthy adults: an interim analysis","volume":"27","author":"Choi","year":"2021","journal-title":"Nat Med"},{"key":"10.1016\/j.micinf.2022.105082_bib12","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2114114","article-title":"Waning of BNT162b2 vaccine protection against SARS-CoV-2 infection in Qatar","author":"Chemaitelly","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.micinf.2022.105082_bib13","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1056\/NEJMoa2109072","article-title":"COVID-19 breakthrough infections in vaccinated health care workers","volume":"385","author":"Bergwerk","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.micinf.2022.105082_bib14","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.dsx.2021.05.001","article-title":"Breakthrough COVID19 infections after vaccinations in healthcare and other workers in a chronic care medical facility in New Delhi, India","volume":"15","author":"Tyagi","year":"2021","journal-title":"Diabetes Metabol Synd Clin Res Rev"},{"key":"10.1016\/j.micinf.2022.105082_bib15","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/S0140-6736(22)00090-3","article-title":"Breakthrough infections with SARS-CoV-2 omicron despite mRNA vaccine booster dose","volume":"399","author":"Kuhlmann","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.micinf.2022.105082_bib16","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/s41577-020-0389-z","article-title":"Pre-existing immunity to SARS-CoV-2: the knowns and unknowns","volume":"20","author":"Sette","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.micinf.2022.105082_bib17","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/s41586-020-2550-z","article-title":"SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls","volume":"584","author":"Le Bert","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.micinf.2022.105082_bib18","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/0168-1702(94)00108-O","article-title":"Quantification of individual subgenomic mRNA species during replication of the coronavirus transmissible gastroenteritis virus","volume":"36","author":"Hiscox","year":"1995","journal-title":"Virus Res"},{"key":"10.1016\/j.micinf.2022.105082_bib19","doi-asserted-by":"crossref","first-page":"376","DOI":"10.4049\/jimmunol.2100421","article-title":"Cutting Edge: nucleocapsid vaccine elicits spike-independent SARS-CoV-2 protective immunity","volume":"207","author":"Matchett","year":"2021","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.micinf.2022.105082_bib20","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/s41541-021-00321-8","article-title":"Replicating bacterium-vectored vaccine expressing SARS-CoV-2 Membrane and Nucleocapsid proteins protects against severe COVID-19-like disease in hamsters","volume":"6","author":"Jia","year":"2021","journal-title":"Npj Vaccines"},{"key":"10.1016\/j.micinf.2022.105082_bib21","article-title":"Protection from COVID-19 with a VSV-based vaccine expressing the spike and nucleocapsid proteins","volume":"13","author":"O'Donnell","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.micinf.2022.105082_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109664","article-title":"Combining spike- and nucleocapsid-based vaccines improves distal control of SARS-CoV-2","volume":"36","author":"Dangi","year":"2021","journal-title":"Cell Rep"},{"key":"10.1016\/j.micinf.2022.105082_bib23","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abo0226","article-title":"A\u00a0modified vaccinia Ankara vaccine expressing spike and nucleocapsid protects rhesus macaques against SARS-CoV-2 Delta infection","volume":"7","author":"Routhu","year":"2022","journal-title":"Sci Immunol"},{"key":"10.1016\/j.micinf.2022.105082_bib24","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/sj.gt.3302675","article-title":"Chimpanzee-origin adenovirus vectors as vaccine carriers","volume":"13","author":"Tatsis","year":"2006","journal-title":"Gene Ther"},{"key":"10.1016\/j.micinf.2022.105082_bib25","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1186\/s12985-021-01712-y","article-title":"Hepatitis B virus polymerase-specific T cell epitopes shift in a mouse model of chronic infection","volume":"18","author":"Hasanpourghadi","year":"2021","journal-title":"Virol J"},{"key":"10.1016\/j.micinf.2022.105082_bib26","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.4049\/jimmunol.1302029","article-title":"The effect of adjuvanting cancer vaccines with herpes simplex virus glycoprotein D on melanoma-driven CD8+ T cell exhaustion","volume":"193","author":"Zhang","year":"2014","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.micinf.2022.105082_bib27","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/nm1704","article-title":"Targeting of antigen to the herpesvirus entry mediator augments primary adaptive immune responses","volume":"14","author":"Lasaro","year":"2008","journal-title":"Nat Med"},{"key":"10.1016\/j.micinf.2022.105082_bib28","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1038\/nprot.2010.134","article-title":"An efficient method of directly cloning chimpanzee adenovirus as a vaccine vector","volume":"5","author":"Zhou","year":"2010","journal-title":"Nat Protoc"},{"key":"10.1016\/j.micinf.2022.105082_bib29","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.jviromet.2010.08.006","article-title":"Generation of VSV pseudotypes using recombinant \u0394G-VSV for studies on virus entry, identification of entry inhibitors, and immune responses to vaccines","volume":"169","author":"Whitt","year":"2010","journal-title":"J\u00a0Virol Methods"},{"key":"10.1016\/j.micinf.2022.105082_bib30","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1016\/j.mayocp.2020.07.024","article-title":"COVID-19 and sex differences","volume":"95","author":"Haitao","year":"2020","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.micinf.2022.105082_bib31","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.02370-20","article-title":"Comparison of subgenomic and total RNA in SARS-CoV-2-challenged rhesus macaques","volume":"95","author":"Dagotto","year":"2021","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.micinf.2022.105082_bib32","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1056\/NEJMoa2116597","article-title":"Effect of COVID-19 vaccination on transmission of Alpha and Delta variants","volume":"386","author":"Eyre","year":"2022","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.micinf.2022.105082_bib33","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1001\/jama.2021.23641","article-title":"Association of a third dose of BNT162b2 vaccine with incidence of SARS-CoV-2 infection among health care workers in Israel","volume":"327","author":"Spitzer","year":"2022","journal-title":"JAMA"},{"key":"10.1016\/j.micinf.2022.105082_bib34","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.3390\/vaccines9121503","article-title":"mRNA COVID-19 vaccines and long-lived plasma cells: a complicated relationship","volume":"9","author":"Giannotta","year":"2021","journal-title":"Vaccines"},{"key":"10.1016\/j.micinf.2022.105082_bib35","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1093\/infdis\/jiab540","article-title":"Anti-severe acute respiratory syndrome coronavirus 2 hyperimmune immunoglobulin demonstrates potent neutralization and antibody-dependent cellular cytotoxicity and phagocytosis through N and S proteins","volume":"225","author":"D\u00edez","year":"2022","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.micinf.2022.105082_bib36","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1038\/s41591-021-01386-7","article-title":"CD8+ T cells contribute to survival in patients with COVID-19 and hematologic cancer","volume":"27","author":"Bange","year":"2021","journal-title":"Nat Med"},{"key":"10.1016\/j.micinf.2022.105082_bib37","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abg5669","article-title":"CD8 + T cells specific for conserved coronavirus epitopes correlate with milder disease in patients with COVID-19","volume":"6","author":"Mallajosyula","year":"2021","journal-title":"Sci Immunol"},{"key":"10.1016\/j.micinf.2022.105082_bib38","doi-asserted-by":"crossref","first-page":"10522","DOI":"10.1128\/JVI.00450-10","article-title":"Adenovirus-based vaccines: comparison of vectors from three species of adenoviridae","volume":"84","author":"Chen","year":"2010","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.micinf.2022.105082_bib39","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1128\/JVI.76.6.2667-2675.2002","article-title":"Novel, chimpanzee serotype 68-based adenoviral vaccine carrier for induction of antibodies to a transgene product","volume":"76","author":"Xiang","year":"2002","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.micinf.2022.105082_bib40","series-title":"Pre-clinical testing of two serologically distinct chimpanzee-origin adenovirus vectors expressing spike of SARS-CoV-2","author":"Novikov","year":"2022"},{"key":"10.1016\/j.micinf.2022.105082_bib41","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1126\/science.abn2688","article-title":"Broad anti\u2013SARS-CoV-2 antibody immunity induced by heterologous ChAdOx1\/mRNA-1273 vaccination","volume":"375","author":"Kaku","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.micinf.2022.105082_bib42","doi-asserted-by":"crossref","DOI":"10.1093\/infdis\/jiac042","article-title":"Distinct homologous and variant-specific memory B-cell and antibody response over time after severe acute respiratory syndrome coronavirus 2 messenger RNA vaccination","author":"Haralambieva","year":"2022","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.micinf.2022.105082_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2020.102911","article-title":"Linear B-cell epitopes in the spike and nucleocapsid proteins as markers of SARS-CoV-2 exposure and disease severity","volume":"58","author":"Amrun","year":"2020","journal-title":"EBioMedicine"},{"key":"10.1016\/j.micinf.2022.105082_bib44","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3390\/vaccines5010005","article-title":"Human T cell memory: a dynamic view","volume":"5","author":"Macallan","year":"2017","journal-title":"Vaccines"}],"container-title":["Microbes and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1286457922001526?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1286457922001526?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T14:40:44Z","timestamp":1761144044000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1286457922001526"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":44,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["S1286457922001526"],"URL":"https:\/\/doi.org\/10.1016\/j.micinf.2022.105082","relation":{},"ISSN":["1286-4579"],"issn-type":[{"value":"1286-4579","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Heterologous chimpanzee adenovirus vector immunizations for SARS-CoV-2 spike and nucleocapsid protect hamsters against COVID-19","name":"articletitle","label":"Article Title"},{"value":"Microbes and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.micinf.2022.105082","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Institut Pasteur. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"105082"}}